MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300,380 | -20.1% | 30,038 | -0.7% | 0.00% | – |
| Q2 2023 | $376,108 | -17.6% | 30,258 | -7.1% | 0.00% | – |
| Q1 2023 | $456,250 | -1.5% | 32,566 | +0.6% | 0.00% | – |
| Q4 2022 | $463,330 | -36.3% | 32,378 | +13.8% | 0.00% | – |
| Q3 2022 | $727,000 | -9.2% | 28,453 | +0.8% | 0.00% | – |
| Q2 2022 | $801,000 | -63.6% | 28,220 | -54.7% | 0.00% | -100.0% |
| Q1 2022 | $2,200,000 | -50.6% | 62,350 | -41.3% | 0.00% | 0.0% |
| Q4 2021 | $4,452,000 | -72.2% | 106,250 | -67.5% | 0.00% | -75.0% |
| Q3 2021 | $16,038,000 | +317.8% | 326,792 | +255.2% | 0.00% | +300.0% |
| Q2 2021 | $3,839,000 | +10.7% | 92,007 | -5.4% | 0.00% | 0.0% |
| Q1 2021 | $3,468,000 | +84.4% | 97,300 | +45.2% | 0.00% | – |
| Q4 2020 | $1,881,000 | – | 67,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |